Tekla Capital Management LLC Heron Therapeutics, Inc. Transaction History

Tekla Capital Management LLC

  • $2.53 Billion
  • Q2 2023

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021
SELL
$13.27 - $18.48 $1.74 Million - $2.42 Million
-131,183 Closed
0 $0
Q1 2020

May 14, 2020
BUY
$10.23 - $24.56 $729,818 - $1.75 Million
71,341 Added 119.22%
131,183 $1.54 Million
Q4 2019

Feb 13, 2020
BUY
$17.42 - $26.61 $1.04 Million - $1.59 Million
59,842 New
59,842 $1.41 Million

Others Institutions Holding HRTX

# of Institutions
193
Shares Held
129M
Call Options Held
94.7K
Put Options Held
148K
View Full List

About HERON THERAPEUTICS, INC.

HRTX Quotes by TradingView
  • Ticker HRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,774,000
  • Market Cap $227M
  • Description
  • Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...
More about HRTX
Track This Portfolio

Track Tekla Capital Management LLC Portfolio

Follow Tekla Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tekla Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tekla Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email